Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran, 14399-57131, Iran.
Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran, 14399-57131, Iran.
Anal Biochem. 2022 Aug 15;651:114697. doi: 10.1016/j.ab.2022.114697. Epub 2022 Apr 26.
Breast cancer is the prevalent disease in women, and diagnosis of it in early stage and takes preventive measures is very critical. Recently, circulating microRNAs have emerged as promising early biomarkers of cancer. MiR-21 and miR-155 are two significant biomarkers that act as oncomir in breast cancer. In this study, to detect both microRNAs in one test simultaneously, a novel colorimetric nanobiosensor was developed upon the peroxidation property of a specific G-quadruplex nanostructure. The nanostructure forms a DNA Nano-Tweezers after self-assembly of three DNA oligonucleotides with target sequences, and TMB (2, 2'-azino-bis (3-ethylbenzothiazo-line-6-sulfonic acid)) is used as a reporter to produce color. The high sensitivity of the nanobiosensor was determined (in buffer and blood) using different concentrations of target sequences with a linear response range from 0 to 10 nM, and detection limit of 0.38 nM (R = 0.98). The method precisely detected target sequences from non-target sequences in both buffer and blood media. These findings demonstrate, the nanobiosensor is superior to most previous published works due to its simultaneous dual detection, simplicity, low response time, and cost. The analytical data is convenient for accurately use for clinical purposes to detect breast cancer in early stage, more significantly.
乳腺癌是女性中最常见的疾病,早期诊断和采取预防措施非常关键。最近,循环 microRNAs 已成为癌症有前途的早期生物标志物。miR-21 和 miR-155 是两种重要的生物标志物,在乳腺癌中作为致癌 miRNA 发挥作用。在这项研究中,为了在一次测试中同时检测这两种 microRNAs,开发了一种新颖的比色纳米生物传感器,该传感器利用特定 G-四链体纳米结构的过氧化特性。该纳米结构在具有目标序列的三个 DNA 寡核苷酸自组装后形成 DNA 纳米镊子,并且 TMB(2,2'-联氮双(3-乙基苯并噻唑啉-6-磺酸))被用作产生颜色的报告分子。使用不同浓度的目标序列在缓冲液和血液中确定了纳米生物传感器的高灵敏度(在缓冲液和血液中),线性响应范围从 0 到 10 nM,检测限为 0.38 nM(R=0.98)。该方法能够精确地从缓冲液和血液介质中的非目标序列中检测到目标序列。这些发现表明,由于该纳米生物传感器具有同时双重检测、简单、低响应时间和低成本的优点,优于大多数以前发表的工作。分析数据方便用于临床目的,更重要的是,可以早期准确地用于检测乳腺癌。